WSG/AGO-Mamma phase III trial: First toxicity analysis of a German intergroup study for patients with primary breast cancer and 1–3 positive axillary lymph nodes. Comparison of six cycles FEC or CMF chemotherapy with four cycles EC followed by four cycles of docetaxel